The FDA has faced significant layoffs, losing hundreds of specialized employees in fields like surgical robotics and artificial intelligence. These staff members were critical to monitoring the safety and efficacy of advanced medical technologies amidst the rapid pace of innovation. The layoffs disproportionately impacted teams responsible for evaluating emerging health threats, and medical devices, raising concerns that public safety could be compromised as the agency navigates funding from industry fees, which constitute nearly half of its $7.2 billion budget.
In recent layoffs, the FDA lost hundreds of specialized staff crucial for monitoring safety in medical devices and advancing healthcare technologies.
The FDA's staffing cuts have raised concerns about the safety of medical devices amid rapid technological advancements.
Collection
[
|
...
]